Clec9A binding agents
US11001631B2 · kind B2 · utility
5Cited by
4References
17Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 6, 2017 |
| Grant date | May 11, 2021 |
| Priority date | — |
| Expiry date | Jan 30, 2038 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates, in part, to agents that bind Clec9A and their use as diagnostic and therapeutic agents. The present invention further relates to pharmaceutical compositions comprising the Clec9A binding agents and their use in the treatment of various diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.